Hogar y Estilo de Vida
5 hábitos para añadir años a tu vida
Ver más
Políticas Médicas
Las políticas médicas son documentos que definen el reconocimiento de cubierta para tecnologías, procedimientos y tratamientos. Las declaraciones de necesidad médica en las políticas, sobre si una tecnología, procedimiento, tratamiento, suplido, equipo, medicamento u otro servicio mejora el resultado en la salud de la población para la cual dicha tecnología o tratamiento fue diseñado se basan en evidencia científica, estudios clínicos y opiniones profesionales de nuestros proveedores y de las organizaciones médicas reconocidas.
Cada documento desplegado en este sitio Web se provee con propósitos informativos solamente y no es una autorización, explicación de beneficios o un contrato. El recibir beneficios está sujeto a la satisfacción de todos los términos y condiciones de la cubierta. La tecnología médica cambia constantemente y nos reservamos el derecho de revisar y actualizar nuestras políticas periódicamente.
| ID | Título | Última Revisión | Siguiente Revisión | Descripción | Acceso |
|---|---|---|---|---|---|
| 11.003.014 | Noninvasive Fetal Rhd Genotyping Using Cell-Free Fetal Dna | Sep 12, 2024 | Sep 20, 2025 | Rhesus d (rhd)-negative women who are exposed to rhd-positive red blood cells can develop anti-rhd... | Ver |
| 11.003.015 | Gene Expression Profile Testing And Circulating Tumor Dna Testing For Predicting Recurrence In Colon Cancer | Sep 18, 2024 | Sep 20, 2025 | Gene expression profile (gep) and circulating tumor dna (ctdna) tests have been developed for use as... | Ver |
| 11.003.016 | Genetic Testing For Pten Hamartoma Tumor Syndrome | Mar 10, 2025 | Mar 20, 2026 | The pten hamartoma tumor syndrome (phts) includes several syndromes with heterogeneous clinical symptoms,... | Ver |
| 11.003.017 | Genetic Testing For Hereditary Hearing Loss | May 12, 2024 | May 20, 2025 | Hearing loss is a common birth defect. approximately 1 in 500 newborns in developed countries is affected by... | Ver |
| 11.003.018 | Chromosomal Microarray Testing For The Evaluation Of Pregnancy Loss | Sep 19, 2024 | Sep 20, 2025 | Chromosomal microarray (cma) testing of fetal tissue or placental tissue derived from the fetal genotype has... | Ver |
| 11.003.020 | Genetic Testing For Lactase Insufficiency | Jul 17, 2024 | Policy Archived | Genetic testing of adults with suspected lactase insufficiency is proposed as an alternative to current... | Ver |
| 11.003.021 | Gene Expression Testing In The Evaluation Of Patients With Stable Ischemic Heart Disease | Apr 20, 2021 | Policy Archived | Expression levels of various genes in circulating white blood cells or whole blood samples have been reported... | Ver |
| 11.003.022 | Genetic Testing For Li-Fraumeni Syndrome | Aug 20, 2024 | Aug 20, 2025 | Li-fraumeni syndrome (lfs) is a cancer predisposition syndrome associated with the development of several... | Ver |
| 11.003.023 | General Approach To Evaluating The Utility Of Genetic Panels | Jan 21, 2025 | Jan 20, 2026 | Genetic panel testing offers potential advantages and disadvantages compared with direct sequence analysis.... | Ver |
| 11.003.025 | Genetic Testing For Developmental Delay/Intellectual Disability, Autism Spectrum Disorder, And Congenital Anomalies | Nov 22, 2024 | Nov 20, 2025 | Chromosomal microarray (cma) testing has been proposed for the detection of genetic imbalances in infants or... | Ver |
| 11.003.026 | Comprehensive Genomic Profiling for Selecting Targeted Cancer Therapies | Mar 20, 2025 | Nov 20, 2025 | Comprehensive genomic profiling offers the potential to evaluate a large number of genetic markers at a... | Ver |
| 11.003.027 | Gene Variants Associated With Breast Cancer In Individuals At High Breast Cancer Risk. | Sep 12, 2024 | Sep 20, 2025 | It is estimated that 3% to 5% of women presenting for assessment for hereditary breast/ovarian cancer risk... | Ver |
| 11.003.028 | Genetic Testing For Lynch Syndrome And Other Inherited Colon Cancer Syndromes | Dec 05, 2024 | Oct 20, 2025 | Genetic testing is available for both those with and those at risk for various types of hereditary cancer.... | Ver |
| 11.003.029 | Epithelial Cell Cytology In Breast Cancer Risk Assesment And High-Risk Patient Management (Ductal Labage And Suction Collection Systems) | May 20, 2019 | Policy Archived | In summary, the available literature regarding ductal lavage and suction collection systems for breast cancer... | Ver |
| 11.003.030 | Genetic Testing For Brca1 Or Brca2 For Hereditary Breast/Ovarian Cancer Syndrome And Other High-Risk Cancers | Feb 10, 2025 | Sep 20, 2025 | Hereditary breast and ovarian cancer syndrome describe the familial cancer syndromes related to variants in... | Ver |
| 11.003.031 | Genetic Testing For Hereditary Hemochromatosis | Jul 10, 2024 | Policy Archived | Hereditary hemochromatosis (hh), a common genetic disorder of iron metabolism, can lead to inappropriate iron... | Ver |
| 11.003.032 | Analysis Of Human Dna In Stool Samples As A Technique For Colorectal Cancer Screening | Jan 20, 2025 | Jan 20, 2026 | Of safety and effectiveness data (ssed): cologuard. august 2014. accessed oct 21,... | Ver |
| 11.003.033 | Análisis de los patrones proteómicos séricos para identificar el cáncer de ovari | May 12, 2016 | Policy Archived | ... | Ver |
| 11.003.034 | Genetic And Protein Biomarkers For The Diagnosis And Cancer Risk Assessment Of Prostate Cancer | Dec 20, 2024 | Dec 20, 2025 | Various genetic and protein biomarkers are associated with prostate cancer. these tests have the potential to... | Ver |
| 11.003.035 | Assays Of Genetic Expression In Tumor Tissue As A Technique To Determine Prognosis In Patients With Breast Cancer | Dec 06, 2024 | Dec 20, 2025 | Laboratory tests have been developed to detect the expression, via messenger rna, of different genes in... | Ver |
